Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mounjaro
Mounjaro
As Lilly surges, headwinds against its weight loss drugs are growing
Pharma Voice
Wed, 05/15/24 - 11:18 am
Eli Lilly
Mounjaro
drug pricing
earnings
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
Fierce Biotech
Wed, 05/1/24 - 10:55 am
Eli Lilly
Gateway Labs
incubators
Mounjaro
biotech
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Novo Nordisk
Eli Lilly
earnings
obesity
weight loss
GLP-1 agonist
Ozempic
Wegovy
Zepbound
Mounjaro
Lilly to buy injectable drug plant in manufacturing ramp-up
BioPharma Dive
Mon, 04/22/24 - 05:54 pm
Eli Lilly
drug manufacturing
Mounjaro
Zepbound
Wisconsin
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says
Reuters
Wed, 04/17/24 - 11:21 am
drug shortages
Eli Lilly
Zepbound
Mounjaro
diabetes
weight loss
Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says
Fierce Pharma
Tue, 04/2/24 - 10:03 pm
Eli Lilly
Mounjaro
drug shortages
diabetes
Could Viking Therapeutics Become the Next Eli Lilly?
Motley Fool
Fri, 03/22/24 - 09:27 am
Viking Therapeutics
Eli Lilly
weight loss
VK-2735
Zepbound
Mounjaro
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
Medical Marketing and Media
Wed, 03/20/24 - 09:43 pm
GLP-1 agonist
PD-1 inhibitors
Wegovy
Ozempic
Zepbound
Mounjaro
Eli Lilly could launch obesity drug in India next year, CEO says
Reuters
Wed, 02/28/24 - 11:05 am
Eli Lilly
Mounjaro
India
Should ACA plans cover weight loss drugs?
Stat
Tue, 02/20/24 - 05:44 pm
ACA
Obamacare
weight loss
obesity
CMS
Wegovy
Mounjaro
Britain sees launch of Lilly's weight-loss drug Mounjaro
Reuters
Wed, 02/14/24 - 11:31 am
Eli Lilly
Mounjaro
weight loss
UK
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
depression
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Lilly expects strong 2024 profit on rising weight-loss drug demand
Reuters
Tue, 02/6/24 - 10:16 am
Eli Lilly
earnings
Zepbound
Mounjaro
Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains
Fierce Pharma
Tue, 02/6/24 - 09:33 am
Eli Lilly
tirzepatide
Novo Nordisk
Zepbound
Mounjaro
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
obesity
weight loss
FDA website shows limited availability of some doses of Lilly's Mounjaro
Reuters
Mon, 02/5/24 - 10:12 am
FDA
drug shortages
Eli Lilly
Mounjaro
Lilly's weight-loss drug Mounjaro coming to UK after pen cleared
Reuters
Thu, 01/25/24 - 09:00 pm
Eli Lilly
Mounjaro
UK
obesity
diabetes
Lilly's Mounjaro dose in limited availability in US through next month
Reuters
Wed, 01/24/24 - 11:39 pm
Eli Lilly
Mounjaro
drug shortages
Pages
1
2
3
4
next ›
last »